These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7643625)
1. In vitro study of THP-doxorubicin retention in human leukemic cells using confocal laser microspectrofluorometry. Pignon B; Morjani H; Vilque JP; Millot JM; Simon G; Lartigue B; Etienne JC; Potron G; Manfait M Leukemia; 1995 Aug; 9(8):1361-7. PubMed ID: 7643625 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of multidrug resistance phenotype on medullary specimens from patients with acute leukemia by determination of nuclear efflux of tetrahydropyranyl-doxorubicin. Approach by confocal laser microspectrofluorometry]. Morjani H; Pignon B; Vilque JP; Millot JM; Lartigue B; Simon G; Etienne JC; Potron G; Manfait M Ann Biol Clin (Paris); 1996; 54(1):9-15. PubMed ID: 8731789 [TBL] [Abstract][Full Text] [Related]
3. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry. Sebille S; Morjani H; Poullain MG; Manfait M Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978 [TBL] [Abstract][Full Text] [Related]
4. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247 [TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma. Solary E; Bidan JM; Calvo F; Chauffert B; Caillot D; Mugneret F; Gauville C; Tsuruo T; Carli PM; Guy H Leukemia; 1991 Jul; 5(7):592-7. PubMed ID: 1677057 [TBL] [Abstract][Full Text] [Related]
6. [Anthracycline resistance: cytofluorometric study on infantile lymphoblastic leukemia]. Limonta M; Ubezio P Medicina (Firenze); 1989; 9(4):406-8. PubMed ID: 2634227 [TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia. Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999 [TBL] [Abstract][Full Text] [Related]
8. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123 [TBL] [Abstract][Full Text] [Related]
10. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults]. Li QH; DU X; Huang ZL; Luo CW; Zhong LY; Lin W Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1195-7. PubMed ID: 16029595 [TBL] [Abstract][Full Text] [Related]
12. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294 [TBL] [Abstract][Full Text] [Related]
13. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia]. Shman TV; Belevtsev MV; Buglova SE Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010 [TBL] [Abstract][Full Text] [Related]
14. Can cytotoxic activity of anthracyclines be related to DNA damage? Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255 [TBL] [Abstract][Full Text] [Related]
15. Uptake and intracellular distribution of doxorubicin metabolites in B-lymphocytes of chronic lymphocytic leukemia. Dessypris EN; Brenner DE; Baer MR; Hande KR Cancer Res; 1988 Feb; 48(3):503-6. PubMed ID: 3257165 [TBL] [Abstract][Full Text] [Related]
16. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines. Taatjes DJ; Fenick DJ; Koch TH Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398 [TBL] [Abstract][Full Text] [Related]
17. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786 [TBL] [Abstract][Full Text] [Related]
18. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675 [TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells. Carrion C; de Madariaga MA; Domingo JC Life Sci; 2004 Jun; 75(3):313-28. PubMed ID: 15135652 [TBL] [Abstract][Full Text] [Related]